2nd Symposium on Molecular Radiotherapy Dosimetry: The future of theragnostics

2nd Symposium on Molecular Radiotherapy Dosimetry: The future of theragnostics is organized by European Federation of Organisations for Medical Physics (EFOMP) and will be held from Nov 13 - 15, 2025 at War Museum Athens, Athens, Attica, Greece.

Aims:
To review and discuss ongoing developments in radionuclide internal dosimetry at a time of rapid expansion of theragnostics and molecular radiotherapy, and to consider the way ahead with informed treatments for patients’ benefit.

Scientific topics:

• Molecular Radiotherapy development including regulatory aspects:
  • Radiopharmaceutical development
  • Software and tools for Molecular Radiotherapy
  • Regulatory aspects
• Dosimetry methodology:
  • Small scale dosimetry (including cellular and small animal dosimetry)
  • Quantitative imaging and imaging protocols
  • Pharmacokinetic modelling including surrogate emitter imaging
  • Absorbed dose calculation algorithms
• Preclinical and Clinical dosimetry, including clinical trials:
  • Radioimmunotherapy
  • Peptide receptor radionuclide therapy
  • PSMA therapy
  • Radioiodine therapy
  • ¹³¹I mIBG therapy
  • Alpha, Auger and emerging therapies
  • Selective Internal Radiotherapy
• Radiobiology including absorbed dose-effect relationship:
  • Experimental radiobiology (preclinical)
  • Clinical radiobiology
  • Radiobiology models
  • Therapies involving combined irradiation (internal/external)
• Emerging approaches:
  • Theragnostic approaches
  • Digital twins
  • AI in dosimetry
• QA, standardisation of dosimetry including risk assessment:
  • Metrology
  • Standardisation
  • Assessment of uncertaintiesa